Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Astrocytoma, IDH-Mutant, Grade 4

Clinical trial condition

Recurrent Astrocytoma, IDH-Mutant, Grade 4

Explore clinical trials studying Recurrent Astrocytoma, IDH-Mutant, Grade 4. Study availability and eligibility vary by location and protocol.

5 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Astrocytoma, IDH-Mutant, Grade 4 trial results

Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NCT06860594

Conditions: Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

View all 43 locations

View Trial Details

Recruiting

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

NCT06815029

Conditions: Astrocytoma, Glioblastoma, Glioma, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

NCT07544992

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

NCT07301268

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +17 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

NCT05789394

Conditions: Astrocytoma, Astrocytoma, Grade IV, Glioblastoma, +10 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details